ArticleBMJ (Clinical research ed.)2025

The efficacy and safety of thymosin α1 for sepsis (TESTS): multicentre, double blinded, randomised, placebo controlled, phase 3 trial.

PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.